Home › Sakit sa Puso at Ugat ng Dugo › Tennessee › Nashville
Pag-aaral pangklinika para sa Sakit sa Puso at Ugat ng Dugo sa Nashville, TN
Isang pag-aaral para sa Sakit sa Puso at Ugat ng Dugo ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Nashville. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Nagre-recruitPhase 4
- TriStar Centennial Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
Nagre-recruit
- Saint Thomas Research Institute, Nashville
Improving Veteran Referral to Cardiac Rehabilitation
Nagre-recruit
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Product Surveillance Registry
Nagre-recruitObservasyonal na pag-aaral
- Nashville, Nashville
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Nagre-recruit
- Vanderbilt University Medical Center, Nashville
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Nagre-recruitPhase 3
- Vanderbilt Univ Medi Cen, Nashville
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Nagre-recruit
- Vanderbilt University Medical Center, Nashville
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
- Meharry Medical College, Nashville
- Nashville VA Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Nagre-recruitPhase 2
- Vanderbilt University Medical Center, Nashville
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Nagre-recruitPhase 3
- Research Site, Nashville
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Nagre-recruitPhase 3
- Ascension Saint Thomas, Nashville
Global Paradise System US Post Approval Study
Nagre-recruitObservasyonal na pag-aaral
- Ascension Saint Thomas, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Nagre-recruit
- Vanderbilt, Nashville
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Nagre-recruitPhase 2
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Nagre-recruit
- Centennial Medical Center, Nashville
Randomized Trial of SGLT2i in Heart Transplant Recipients
Nagre-recruitPhase 4
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Gut Microbiota in Metabolic Surgery
Nagre-recruitObservasyonal na pag-aaral
- Vanderbilt_University MC, Nashville
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Nagre-recruit
- Centennial Medical Center, Nashville
Pag-aaral para sa Sakit sa Puso at Ugat ng Dugo sa ibang lungsod
- Boston, MA37 pag-aaral
- New York City, NY33 pag-aaral
- Washington, DC28 pag-aaral
- Houston, TX24 pag-aaral
- Dallas, TX23 pag-aaral
- Cleveland, OH22 pag-aaral
- Atlanta, GA22 pag-aaral
- Chicago, IL21 pag-aaral
- Philadelphia, PA21 pag-aaral
- Pittsburgh, PA20 pag-aaral
- St. Louis, MO20 pag-aaral
- San Francisco, CA18 pag-aaral
Iba pang pag-aaral sa Nashville
- Non-Small Cell Lung Cancer97 pag-aaral
- Kanser sa Suso81 pag-aaral
- Metastatic Cancer70 pag-aaral
- Colorectal Cancer69 pag-aaral
- Kanser (lahat ng uri)65 pag-aaral
- Kanser sa Ovary49 pag-aaral
- Kanser sa Prostate43 pag-aaral
- Kanser sa Baga40 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg39 pag-aaral
- Kanser sa Pancreas39 pag-aaral
- Kanser ng Endometrium38 pag-aaral
- Melanoma33 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.